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The cell-surface expression of GM1 ganglioside was studied using various cultured cells, including brain-derived endothelial cells, astrocytes,
neuroblastoma cells (SH-SY5Y), and pheochromocytoma cells (PC12). GM1 ganglioside was detected only on the surface of native and nerve-
growth-factor (NGF)-treated PC12 cells. We investigated whether GM1 ganglioside on the surface of these cells is sufficiently potent to induce the
assembly of an exogenous soluble amyloid β-protein (Aβ). A marked Aβ assembly was observed in the culture of NGF-treated PC12 cells. Notably,
immunocytochemical study revealed that, despite the ubiquitous surface expression of GM1 ganglioside throughout cell bodies and neurites, Aβ
assembly initially occurred at the terminals of SNAP25-immunopositive neurites. Aβ assembly in the culture was completely suppressed by the
coincubation of Aβ with the subunit B of cholera toxin, a natural ligand for GM1 ganglioside, or 4396C, a monoclonal antibody specific to GM1-
ganglioside-bound Aβ (GAβ). In primary neuronal cultures, Aβ assembly initially occurred at synaptophysin-positive sites. These results suggest that
the cell-surface expression of GM1 ganglioside is strictly cell-type-specific, and that expression of GM1 ganglioside on synaptic membranes is unique
in terms of its high potency to induce Aβ assembly through the generation of GAβ, which is an endogenous seed for Aβ assembly in Alzheimer brain.
© 2007 Elsevier B.V. All rights reserved.Keywords: Alzheimer's disease; Amyloid; Amyloid β-protein; Seed; Ganglioside; Synapse; PC12 cell; Primary neuron1. Introduction
The deposition of amyloid β-protein (Aβ) is a fundamental
step in the early stage of Alzheimer's disease (AD). However, it
remains to be determined how soluble Aβ starts to assemble and
deposit in the brain and why this pathological process occurs in
aging- and brain-region-dependent manners. We previously
identified a unique Aβ species that is strongly bound to GM1
ganglioside in the AD brain [1]. GM1-ganglioside-bound Aβ
(GAβ) showed an extremely high aggregation potential and an
altered immunoreactivity [1,2]. On the basis of these GAβ
characteristics, we hypothesized that Aβ adopts an altered
conformation through binding to GM1 ganglioside, and then
acts as a seed for Aβ assembly in the brain [1–3]. This
hypothesis has been supported by various in vitro studies to date⁎ Corresponding author. Tel.: +81 562 44 5651x5002; fax: +81 562 44 6594.
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doi:10.1016/j.bbamem.2007.01.009[4–9]. Recently, we have confirmed GAβ generation in AD
brains and the brains of aged monkeys using a novel monoclonal
antibody specific to GAβ [10]. Furthermore, Wakabayashi et al.
have recently reported that GM1-ganglioside-mediated Aβ
assembly can occur on the surface of cultured cells [11].
According to recent studies by other groups, gangliosides
may also be involved in the induction of the assembly and
deposition of host-derived proteins in other human amyloidoses.
Gellermann et al. have shown that serum amyloid A, a
constituent of amyloid deposited in visceral organs following
prolonged inflammation, forms fibrils through interaction with
GM1 ganglioside on cultured humanmonocytes [12].Moreover,
Wang et al. have reported that the fibril formation of calcitonin, a
protein recently identified as a constituent of thyroid-cancer-
associated amyloid [13,14], is enhanced in the presence of a
ganglioside mixture [15]. These results, together with results of
previous studies by our group and other groups, strongly suggest
that the interaction of an amyloidogenic protein with membrane
Fig. 1. Dot blot analysis of cell lysates of various cultures. Cell lysates containing
0.5 μg of protein were dot-blotted onto nitrocellulose membranes and incubated
with antibodies for GM1, GM3 andGD3 gangliosides. EC, endothelial cells; Ast,
astrocytes; Co, coculture of endothelial cells and astrocytes; SY5Y, SH-SY5Y
neuroblastoma cells; PC12, PC12 cells without NGF treatment; PC12N, PC12
cells with NGF treatment; neuron, primary cultured neurons (div 25).
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induction of human amyloidoses.
The next question to be answered is how a ganglioside
predisposes a given host-derived protein to form pathological
amyloid fibrils. In the case of GM1 ganglioside, we have recently
reported that risk factors for AD development, including aging
and apolipoprotein E4 expression, increase the GM1 ganglioside
level of detergent-resistant membrane microdomains (DRMs) in
synaptic membranes [16]. Moreover, we have also shown that the
increase in the GM1 ganglioside level of DRMs is sufficient to
facilitate Aβ assembly [16]. These findings imply that an increase
in GM1 ganglioside level in a particular membrane microdomain
of neurons underlies the assembly and deposition of Aβ in the
brain. Notably, supporting evidence to this possibility has re-
cently been provided by other group. Molander-Melin et al. per-
formed a quantitative analysis of gangliosides using AD brains
and found a significant increase in the GM1 ganglioside level of
DRMs isolated from the cerebral cortices of AD brains [17].
The aim of this study is to determine whether the
biosynthesis and cell-surface expression of GM1 ganglioside
are cell-type-specific and how GM1-ganglioside-mediated Aβ
assembly occurs on the cell surface.
2. Materials and methods
2.1. Cell culture
The human brain microvascular endothelial cells and human brain astrocytes
used were purchased from Dainippon Pharmaceutical Inc. (Osaka, Japan). The
cells were cultured in CS-C medium (Dainippon Pharmaceutical Inc.) in
collagen-coated flasks in humidified 5% CO2 at 37 °C. For coculture, the
endothelial cells and astrocytes (1:1) were cultured under the same conditions for
1 week. Human neuroblastoma SH-SY5Y cells were cultured in Dulbecco's
modified Eagle's medium (DMEM)/Ham's F-12 medium (Invitrogen, Carlsbad,
CA) supplemented with 10% fetal bovine serum (FBS) (Invitrogen) in
humidified 5% CO2 at 37 °C. PC12 cells were cultured in DMEM supplemented
with 10% heat-inactivated horse serum and 5% FBS. For their differentiation,
PC12 cells were plated on 10-cm poly-L-lysine-coated (10 mg/ml) dishes at
density of 20,000 cells/cm2 and cultured for 6 days in DMEM supplemented
with 100 ng/ml nerve growth factor (NGF; Alomone Labs, Jerusalem, Israel).
The cells were treated with synthetic Aβ1–40 (Aβ) (Peptide Inst., Osaka,
Japan), and then subjected to Western blot analysis, immunocytochemistry and
thioflavin-S (ThS) fluorescence staining. We prepared primary neuronal cultures
according to previous report [18]. Briefly, hippocampi of E18/E19 rat brains
were dissociated by enzyme digestion with papain followed by brief mechanical
trituration. Cells were plated on poly-L-lysine- (SIGMA-Aldrich, St. Louis, MO)
treated glass coverslips (12 mm in diameter). Cultures were plated and
maintained in Neurobasal media (Invitrogen) supplemented with B-27 (Invitro-
gen) and L-glutamine for 25 days in vitro (div). The cells were treated with
soluble Aβ, and then subjected to immunocytochemistry and ThS treatment.
2.2. Dot blot analysis of gangliosides of various cultured cells
The cultured cells were harvested with phosphate-buffered saline (PBS) and
centrifuged at 800×g for 10 min. Cell pellets were suspended in a solution of
5 mM Tris–HCl (pH 7.4), 2 mM EDTA, 0.5% Nonidet P-40 and a protease
inhibitor (Complete™), and sonicated using a probe-type sonicator (TOMY
UD-201, Tokyo, Japan) at a power of 200 W for 10 s on ice. Protein con-
centration was determined using a bicinchoninic acid protein assay kit (Pierce,
Rockford, IL). Samples (0.5 μg) were blotted onto a nitrocellulose membrane.
The blots were incubated with an anti-GM1 ganglioside polyclonal antibody
(anti-GM1) (1:500) (Calbiochem, San Diego, CA), an anti-GM3 ganglioside
monoclonal antibody (GMR6) (1:1,000) (Seikagaku Co., Ltd., Tokyo, Japan),
and an anti-GD3 ganglioside monoclonal antibody (R24) (1:500) (Calbiochem,San Diego, CA). The blots incubated with antibodies for GM1, GM3 and GD3
gangliosides were then reacted with horseradish-peroxidase-conjugated anti-
rabbit IgG, anti-mouse IgM and anti-mouse IgG, respectively. Bound-enzyme
activity was visualized with an enhanced chemiluminescence (ECL) system
(Amersham Bioscience, Piscataway, NJ).
2.3. Immunocytochemistry and thioflavin-S fluorescence staining
The cultured cells were fixed with −20 °C acetone for 5 min and incubated
with a blocking solution containing 5% goat serum and 5% donkey serum in
phosphate-buffered saline (PBS) (COSMO BIO Co., Tokyo, Japan). The cells
were then incubated overnight at 4 °C with anti-GM1 (1:200), GMR6 (1:100),
and R24 (1:250) or an anti-CD31 polyclonal antibody (H-300) (1:200) in PBS
containing 1% BSA. The cells were also incubated with these antibodies or an
anti-GFAP polyclonal antibody (Z0344) (1:500) for 1 h at room temperature
following permeabilization with 0.1% Triton X-100. After washing with PBS,
the cells were further incubated with a rhodamine-conjugated antibody (1:200)
for GM1, GM3 and GD3 ganglioside stainings or with an Alexa 488-conjugated
antibody (1:200) for CD31 and GFAP stainings. To detect Aβ assembly in the
cultures by ThS fluorescence staining, the cells (PC12N cells or primary
cultured neurons) were fixed in 10% formalin for 10 min and washed in PBS.
Before ThS fluorescence staining, the cells were subjected to immunocyto-
chemistry as follows. The cells were incubated with a blocking solution
containing 10% goat serum in PBS for 20 min following permeabilization with
0.1% Triton X-100. The cells were then incubated overnight at 4 °C with an anti-
SNAP-25 antibody (Stressgen, Victoria, Canada) (1:100), an anti-microtubule-
associated protein 2 (MAP2) antibody (Chemicon, Temecula, CA) (1:1,000) or
an anti-synaptophysin antibody (SIGMA-Aldrich) (1:3,000) in PBS containing
1% BSA. After washing with PBS, the cells were incubated with rhodamine-
conjugated (1:200) or Cy3-conjugated (1:250) second antibodies. For ThS
treatment, the cells were incubated for 10 min in 0.25% potassium
permanganate. After washed in PBS, the cells were incubated in 2% potassium
bisulfite and 1% oxalic acid until they became colorless. Then, after washed in
water, the cells were treated with a solution of 0.015% ThS for 10 min in 50%
ethanol. Finally, the cells were washed in 50% ethanol and water, and mounted
in Vectashield mounting medium (Vector Laboratories, Inc., Burlingame, CA).
2.4. Preparation of seed-free Aβ solutions
Aβ solutions were prepared essentially as previously described [10,19].
Briefly, Aβ (Aβ1–40) was dissolved in 0.02% ammonia solution at 500 μM. To
obtain seed-free Aβ solutions, the prepared solutions were centrifuged at
540,000×g for 3 h using an Optima TL ultracentrifuge (Beckman, USA) to
remove undissolved peptides, which can act as preexisting seeds. The supernatant
was collected and stored in aliquots at −80 °C until use. The Aβ concentration in
the resulting solutions was determined using bicinchoninic acid (BCA) protein
assay kit purchased from Pierce (Rockford, IL). Immediately before use, the
aliquots were thawed and diluted with Tris-buffered saline (TBS: 150 mM NaCl
and 10 mM Tris–HCl, pH 7.4).
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Aβ solutions at 50 μM in DMEM were incubated with the cultured
cells for 24 h at 37 °C, and centrifuged at 540,000×g for 15 min. The
precipitates were subjected to electrophoresis following solubilization inFig. 2. Expression of gangliosides by various cultured cells. The endothelial cells (EC
(SY5Y), native PC12 cells and NGF-treated PC12 cells (PC12N) were incubated with
(−) pretreatment for permeabilization. The endothelial cells and astrocytes were labe
respectively. Insets: with higher range of sensitivity. Bars, 50 μm.formic acid as previously described [16]. Aβ in the gel was blotted onto a
NitroBind membrane (GE Osmonics, Minnetonka, MN). The blot was
incubated overnight at 4 °C with 4G8 (1:1,000), a monoclonal antibody
specific to amino acid residues 17–24 of Aβ, and visualized using an ECL
system.), astrocytes (Ast), coculture of these cells (Co), SH-SY5Y neuroblastoma cells
antibodies for GM1 (A), GM3 (B) and GD3 (C) gangliosides with (+) or without
led with antibodies for CD31 and GFAP that are marker proteins for these cells,
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3.1. Cell-type-specific expression of gangliosides
The synthesis of gangliosides, including GM1, GM3 and
GD3 gangliosides, was examined by the dot blot analysis ofFig. 3. Induction of Aβ assembly in various cultures. (A) Western blot of insoluble
cultures at a final concentration of 50 μM and incubated for 24 h at 37 °C. Soluble Aβ
cells and media were ultracentrifuged, and the precipitates were subjected to Western
blot was reacted with a monoclonal antibody for Aβ (4G8). EC, endothelial cells; As
neuroblastoma cells; PC12, PC12 cells without NGF treatment; PC12N, PC12 cells
Ast, Co, SY5Y, PC12 and PC12N cells and incubated for 24 h at 37 °C. The Aβ assem
with higher range of sensitivity. Bars, 50 μm. (C) Images of phase-contrast microscthe lysates of various cultured cells. GM1 ganglioside was
readily detectable by this method in all the cultured cells
except the endothelial cells (Fig. 1). In contrast to GM1
ganglioside, both GM3 and GD3 gangliosides were detected
only in the coculture of the astrocytes and endothelial cells
(Fig. 1). To exactly determine the cell-surface expression ofAβ assemblies. Soluble Aβ (Aβ1–40) was added to the media of the various
was also incubated in the fresh media. All the incubated mixtures containing the
blot analysis following the solubilization of assembled Aβ in formic acid. The
t, astrocytes; Co, coculture of endothelial cells and astrocytes; SY5Y, SH-SY5Y
with NGF treatment. (B) Soluble Aβ was exogenously added to cultures of EC,
blies formed in the cultures were visualized by ThS fluorescence staining. Inset:
opy of PC12N cells with or without Aβ treatment for 24 h at 37 °C.
Fig. 4. Immunocytochemistry of NGF-treated PC12 cells. PC12 cells treated
with 100 ng/ml NGF were incubated with soluble Aβ (Aβ1–40) at a final
concentration of 50 μM for 2 h at 37 °C. These cells were treated with ThS
following incubation with an antibody for SNAP-25 or MAP2. Bar, 50 μm.
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without pretreatment for permeabilization with 0.1% Triton
X-100. In this experiment, the cell-surface expression of GM1
ganglioside was observed only in the cultures of native and
NGF-treated PC12 cells (Fig. 2A). In accordance with the
result of the dot blot analysis (Fig. 1), the levels of total GM1
and cell-surface GM1 gangliosides were higher in NGF-
treated PC12 cells than in native PC12 cells (Fig. 2A).
Notably, cell-surface expression of GM1 ganglioside in NGF-
treated PC12 cells was observed throughout cell bodies and
neurites (Fig. 2A). In contrast to that of GM1 ganglioside, the
immunoreactivities of GM3 and GD3 gangliosides were
detected only in the coculture of the astrocytes and
endothelial cells (Fig. 2B and C). No cell-surface expression
of GM3 ganglioside was detected in these cells whereas
expression of GD3 ganglioside was detected only on the
surface of astrocytes cocultured with the endothelial cells,
although at a low level, as we have recently reported [20]
(Fig. 2B and C).
3.2. Aβ assembly in the culture of PC12 cells
We then examined the potency of GM1 ganglioside
expressed on the surface of PC12 cells to induce the
assembly of exogenous soluble Aβ. We performed a Western
blot analysis of the cultures incubated with soluble Aβ.
Formation of insoluble Aβ assemblies was observed at a
significant level only in the culture of the NGF-treated PC12
cells (Fig. 3A). Aβ assembly leading to amyloid fibril
formation was determined using ThS, which specifically
reacts with the amyloid structure. Consistent with the result of
the Western blot analysis, a marked ThS fluorescence
intensity was observed in the culture of the NGF-treated
PC12 cells (Fig. 3B). Although the level of ThS fluorescence
intensity was low, Aβ assembly was apparently induced in
the culture of native PC12 cells, which is consistent with a
recent study by other group [11] (Fig. 3B). PC12 cells bearing
amyloid fibrils showed shrinkage and retraction of neuritis of
the cell (Fig. 3C).
3.3. Aβ assembly at neuritic terminals of PC12 cells
We then attempted to determine the site of the NGF-treated
PC12 cells, where Aβ assembly initially occurs following
incubation with exogenous soluble Aβ. The NGF-treated PC12
cells were incubated with soluble Aβ for only a short time (2 h)
so as to exactly specify the initial sites of Aβ assembly. In this
experiment, ThS fluorescence intensity was specifically
observed at the junction between cell bodies and neurites that
were immunostained with an antibody for SNAP-25 but not
with an antibody for MAP2 (Fig. 4).
3.4. GM1-ganglioside-mediated Aβ assembly in the culture of
PC12 cells
To confirm that GM1 ganglioside is directly involved in the
occurrence of Aβ assembly in the culture of NGF-treated PC12cells, we coincubated such cells with subunit B of cholera toxin
(CTX), which is a natural ligand for GM1 ganglioside. The
level of insoluble Aβ assemblies in the culture, which was
determined by the Western blot analysis, markedly decreased in
a CTX-dose-dependent manner (Fig. 5A). The ThS fluores-
cence intensity of the culture also decreased by the coincubation
with CTX (Fig. 5B). To further confirm that the Aβ assembly in
the culture depends on the presence of GM1 ganglioside, we
treated the cells with (±)-threo-1-phenyl-2-decanoylamino-3-
morpholino-1-propanol hydrochloride (PDMP), an inhibitor of
ganglioside synthesis. PDMP treatment markedly suppressed
the Aβ assembly in the culture (Fig. 5C).
3.5. GAβ-dependent Aβ assembly in the culture of PC12 cells
We then investigated whether Aβ assembly occurs in the
culture of NGF-treated PC12 cells through GAβ generation, we
incubated the culture with a monoclonal antibody (4396C),
which is specific to GAβ [10]. As in the case of the incubation
with CTX, 4396C addition to the culture medium significantly
decreased the level of insoluble Aβ assemblies in the culture
(Fig. 6A). The ThS fluorescence intensity of the culture also
decreased by the incubation with 4396C (Fig. 6B). Notably,
4396C suppressed Aβ assembly in the culture even at 0.12%
soluble Aβ. In contrast, 4G8, which is one of the most
prevailing antibodies against Aβ, failed to suppress Aβ
assembly in the culture (Fig. 6B).
3.6. Aβ assembly on synaptic membranes of primary neurons
Finally, we performed experiments using primary neurons
which had been cultured for over 3 weeks to induce mature
Fig. 5. Suppression of Aβ assembly in culture of NGF-treated PC12 cells by incubation with CTX or PDMP. (A) PC12 cells treated with NGF (100 mg/ml) were
incubated with soluble Aβ (Aβ1–40) at a final concentration of 50 μM for 24 h at 37 °C with CTX (SIGMA-Aldrich) at the indicated concentrations. All the incubated
mixtures containing cells and media were ultracentrifuged, and the precipitates were subjected toWestern blot analysis following the solubilization of assembled Aβ in
formic acid. The blot was reacted with a monoclonal antibody for Aβ (4G8). Quantitative densitoscanning was performed. Each column indicates the mean of three
values±1 SD. *p<0.0001. (B) Assembled Aβ in the NGF-treated PC12 cells incubated under the same conditions as those in (A) were visualized by ThS fluorescence
staining. Bar, 50 μm. (C) Assembled Aβ in the NGF-treated PC12 cells incubated with soluble Aβ at a final concentration of 50 μM for 24 h at 37 °C with PDMP
(SIGMA-Aldrich) at the indicated concentrations were visualized by ThS fluorescence staining. Bar, 50 μm. Insets: Dot blots of the cell lysates incubated with
horseradish peroxidase conjugated CTX for determination the expression levels of GM1 ganglioside in the cultures.
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markedly increased in the cultures treated with soluble Aβ for
48 h whereas that was strongly suppressed in the presence of
CTX (Fig. 7B). Primary neurons bearing amyloid fibrils showed
shrinkage and retraction of neuritis of the cell (Fig. 3C). To
precisely determine the initial sites of Aβ assembly, we
performed immunocytochemistry of the cultures treated with
soluble Aβ for only 2 h. The ThS fluorescence staining was
distinctly colocalized with the immunostaining of an antibody
specific to synaptophysin (Fig. 7D). Interestingly, some dots
positive for both synaptophysin and ThS are apparently
enlarged compared with synaptophysine-positive and ThS-
negative dots (Fig. 7D).4. Discussion
Gangliosides are physiological constituents of cellular
membranes and play important roles in the differentiation,
functioning and viability of cells. This is particularly true in
brain. However, it remains to be clarified how the biosynthesis
and cell-surface expression of gangliosides are regulated in
temporal- and brain-region-specific manners [21]. In this study,
the cell-surface expression of GM1 ganglioside was detected
only on PC12 cells although this ganglioside is commonly
biosynthesized by most of the cells examined in this study.
Unlike GM1 ganglioside, GM3 and GD3 gangliosides were
detected only in the coculture of the astrocytes and endothelial
Fig. 6. Suppression of Aβ assembly in culture of NGF-treated PC12 cells by incubation with anti-GAβ antibody (4396C). (A) PC12 cells treated with NGF
(100 mg/ml) were incubated with soluble Aβ (Aβ1–40) at a final concentration of 50 μM for 48 h at 37 °C with 4396C, 4G8 or control mouse IgG at the indicated
concentrations. All the incubated mixtures containing cells and media were ultracentrifuged, and the precipitates were subjected to Western blot analysis following the
solubilization of assembled Aβ in formic acid. The blot was reacted with a monoclonal antibody against Aβ (4G8). Quantitative densitoscanning was performed. Each
column indicates the mean of three values±1 SD. *p<0.005, **p<0.0001. (B) Assembled Aβ in NGF-treated PC12 cells incubated under the same conditions as
those in (A) were visualized by ThS fluorescence staining. Bar, 50 μm.
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surface expression of gangliosides are strictly dependent on the
type and differentiation of cells.
Notably, 4396C potently suppressed Aβ assembly even at its
low concentrations whereas 4G8 failed to do so at the same
concentrations. Taken together with our previous finding that
4396C specifically binds to GAβ and not to monomeric Aβ
[10], it seems likely that 4396C suppressed Aβ assembly
through specific binding to the conformationally altered Aβ
(GAβ), which is required for amyloid fibril formation [10]. It
was previously reported that residues Aβ16–20 likely serve as a
binding sequence during Aβ polymerization [22] and ligands
capable of binding to the midportion of Aβ interfere with Aβ
polymerization [23–25]. It remains to be clarified why 4G8, an
antibody specific to Aβ17–24, failed to suppress Aβ assembly;
however, it is likely that a higher 4G8 concentration is needed to
suppress Aβ assembly than those of 4396C or that 4G8
favorably binds to lateral surface of formed fibrils, as wepreviously reported, rather than binding to the midportion of Aβ
during Aβ assembly [10].
Accumulating evidence suggests that gangliosides, particu-
larly GM1 ganglioside, are involved in the development of the
pathological assembly and deposition of host-derived amyloi-
dogenic proteins, including Aβ, serum amyloid A and
calcitonin, in the early stage of human amyloidoses [1,12,15].
We have recently examined the potency of various gangliosides,
including GM1, GM2, GM3, GM4, GD1a, GD1b, GD3, GT1b,
and GT3 gangliosides, to induce the assembly of wild- and
hereditary-variant-type Aβs in vitro [20]. Among these gang-
liosides, only GM1, GM3 and GD3 gangliosides are sufficiently
potent to induce Aβ assembly [20,26]. This finding seems
pathologically relevant to Aβ deposition in the brain because
GM3 and GD3 gangliosides are preferably expressed on the
surface of cells that form favorable deposition sites for the
hereditary-variant-type Aβs, including Dutch-type, Italian-type,
Iowa-type and Flemish-type Aβs, in the brain [20].
Fig. 7. Immunocytochemistry of primary cultured neurons (div 25). (A) Primary cultured neurons were visualized at 20× with a differential interference contrast
microscope (Olympus IX81, Olympus, Tokyo, Japan). Bar, 10 μm. (B) Assembled Aβ in primary cultured neurons incubated with soluble Aβ (Aβ1–40) at a final
concentration of 50 μM for 48 h at 37 °C in the presence or absence of 1 μM CTX were visualized by ThS fluorescence staining. Bar, 50 μm. (C) Images of phase-
contrast microscopy of primary cultured neurons incubated with soluble Aβ (Aβ1–40) at a final concentration of 50 μM for 48 h at 37 °C. Arrows and arrowheads
indicate amyloid-bearing and amyloid-free neurons, respectively. (D) Primary cultured neurons were incubated with soluble Aβ at a final concentration of 50 μM for
2 h at 37 °C. These cells were treated with ThS following incubation with an antibody specific to synaptophysin. Arrows indicate the positions where assembled Aβ
(ThS) colocalizes with synaptophysin-positive synaptic sites. Bar, 20 μm.
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is biosynthesized broadly in the brain outside the favorable
depositin site of wild-type Aβ in sporadic AD [27]. Thus, it
seems likely that the cell-surface expression of GM1 ganglio-
side, which is required for facilitation of Aβ assembly in thebrain, is not merely dependent on the biosynthesis level of this
ganglioside but rather is induced by as yet unclarified factors. In
this study, Aβ assembly in the culture of the differentiated PC12
cells occurred initially at neuritic terminals, although the cell-
surface expression of GM1 ganglioside was observed
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cultures, Aβ initially assembled at synaptophysin-positive sites,
suggesting that Aβ assembly starts at presynaptic sites. These
results suggest that GM1 ganglioside on synaptic membranes
clusters together, leading to providing favorable milieus for Aβ
assembly. Although GM1-ganglioside-mediated assembly of
amyloidogenic proteins, including Aβ and serum amyloid A, is
not restricted to the case of neurons [11,12], our results suggest
that the expression of GM1 ganglioside on synaptic membranes
is unique in terms of its high potency to induce Aβ assembly.
This possibility is supported by a recent study of Gylys et al.
showing that the level of GM1 ganglioside increase in amyloid-
positive nerve terminals obtained from AD cortex [28]. Notably,
Gylys et al. also examined the size of nerve-terminals of AD
brains and found that amyloid-positive terminals are larger than
amyloid-negative terminals [28]. This finding is consistent with
our observation in this study. Furthermore, our conclusion is
also supported by the result of previous immunohistochemical
study of human brains with early signs of AD, showing that Aβ
starts to deposit in association with neuronal plasma membrane,
especially at presynaptic sites [29].
At this point, it remains to be clarified how the expression of
GM1 ganglioside on synaptic membranes is physiologically
regulated and pathologically altered in AD. Our recent study has
shown that GM1 ganglioside tends to accumulate in the DRMs
of synaptic membranes as affected by risk factors for AD
development, including aging and expression of apolipoprotein
E4, and that these DRMs are apparently distinct from lipid rafts
[16]. Taken together with results of this study, it may be possible
to assume that unique GM1-ganglioside-rich membrane micro-
domains on synaptic membranes are involved in the early stage
of AD by facilitating GAβ generation. A recent study of
Molander-Melin et al. supports the possibility [17]. They
examined the cerebral cortices of AD brains and found an
increase in the GM1 ganglioside level of DRMs isolated from
the frontal cortex but not from the temporal cortex, reflecting
earlier and later stages of AD, respectively. GM1 ganglioside is
likely expressed throughout cell body and neurites of neurons;
however, GM1 ganglioside particularly modulates the neuron-
specific functions of nerve endings, including those associated
with axonal growth and synapse plasticity. In regard to the
regulation of GM1 ganglioside level at these sites, previous
studies suggested that plasma membrane ganglioside sialidase
(PMGS) is involved in this process by the conversion of
polysialilated gangliosides to GM1 ganglioside [30–33]. Thus,
PMGS activity may increase in synaptic membranes prior to
AD development although the sialidase activity in synaptic
membranes decreases with increasing age in mice [34].
Alternatively, turnover of GM1 ganglioside, including its
endocytosis, degradation and recycling, may be perturbed at
neuritic terminals, leading to GM1 ganglioside accumulation at
these sites in AD brain.
5. Conclusions
Collectively, our data indicate that the cell-surface expres-
sion of GM1 ganglioside is strictly cell-type-specific, and thatexpression of GM1 ganglioside on synaptic membranes is
unique in terms of its high potency to induce Aβ assembly
through the generation of GAβ, which is an endogenous seed
for Aβ assembly in AD brain. A future challenge will be to
clarify the mechanism underlying the accumulation of GM1
gangliosides on neuronal membranes, particularly synaptic
membranes, in association with risk factors for AD, including
aging and expression of apolipoprotein E4.
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